The new ABLE 3D Magnetic Stir and Disposable Bioreactor System from AMSBIO provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture. Induced pluripotent stem cells grown in 3D spheroid suspension culture closely resemble embryoid body structures naturally formed by embryonic stem cells. Using an ABLE 3D Bioreactor offers researchers an easy-to-use and affordable tool that provides excellent yield, viability, and high efficiency for the expansion of human iPS stem cells and differentiation. Made of high-density polycarbonate for biocompatibility…

Are you a scientist or clinician working in the wonderful world of cell and gene therapy and drug development? If yes, this is the podcast for you! During this episode of 'Conversations in Drug Development' you can learn more about the 'Recent Trends in Oncology Drug Development'. LISTEN NOW 

Aimed at in-house lawyers who are not already experts in a given technology but would like to know more, each of these three sessions will give an overview of the science as well as jargon-busting tips, followed by some legal considerations and hot topics.To find out more and register, click here - https://www.bristows.com/viewpoint/events/

  Latest News RS&RS Scientific and Native Labs are the latest start-ups to join Stevenage Bioscience Catalyst's (SBC) Lab Hotel. Read more Tessellate BIO Emerges from Stealth. Read more Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies. Read more   Learn more about SBC: https://www.stevenagecatalyst.com/about/  

SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the pace of in vitro drug discovery Early access will further validate the technology and provide feedback on applicability across customer workflows   Cambridge, UK, 18 October 2023: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced the opening of its Early Adopter Programme for its SemaCyte® Microcarrier Platform. The platform overcomes current…

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform, in identifying topology-related off-target events across the genome in cells   Cambridge, UK, 18 October 2023: Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that its INDUCE-seq™ DNA break-mapping technology had been used in…

Click here to view the October 2023 edition of The Meeting Place

To achieve Net Zero in the UK, thousands of businesses and millions of individuals need to change the way they do things every day. Innovate UK EDGE has partnered with sustainability innovators Greenr to give your company a toolkit of practical strategies that will launch you on your Net Zero journey. Find out how action on sustainability can also enhance your reputation, boost employee satisfaction and help with recruitment and retention. Turn your Net Zero ambitions into practical actions and get results! Join us for the exclusive opportunity to measure your company’s carbon footprint with…

Tessellate BIO Emerges from Stealth The Next Generation Synthetic Lethality Precision Oncology Company • The company aims to become a global leader in precision oncology by redefining Synthetic Lethality to treat large, currently unserved patient populations • Lead program targets Alternative Lengthening of Telomeres (ALT) through the FANCM protein complex • Company backed by leading venture firms, BioGeneration Ventures (BGV) and Forbion • World-class leadership team with proven experience as entrepreneurs and deep expertise in drug discovery and precision oncology Amsterdam, the Netherlands…

Bruntwood SciTech, the UK’s leading specialist property provider, founded by Legal & General and Bruntwood in 2018 to support the growth of the life science and tech sectors, has secured £500 million of additional investment and welcomed the UK’s largest local authority pension fund, Greater Manchester Pension Fund (GMPF), to the partnership. GMPF is the first local government pension scheme to make a direct and active investment into a UK-wide science, tech and innovation specialist property platform. The deal demonstrates the role that such funds can play in regenerating the UK’s towns…